Pulmonx (LUNG) Research & Development (2019 - 2025)
Pulmonx (LUNG) reported Research & Development of $4.8 million for Q3 2025, up 29.43% year-over-year from $3.7 million in Q3 2024, and down 8.67% quarter-over-quarter from $5.3 million in Q2 2025.
Pulmonx (LUNG) Research & Development (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has 7 years of Research & Development data on file, last reported at $4.8 million in Q3 2025.
- Research & Development for Q3 2025 came in at $4.8 million, up 29.43% year-over-year; the trailing twelve-month figure through Sep 2025 was $18.9 million (up 8.27% YoY), and the FY2024 annual result was $17.6 million, down 2.82% from the prior year.
- Research & Development fell to $4.8 million in Q3 2025 per LUNG's latest filing, from $5.3 million in the prior quarter.
- Over five years, Research & Development peaked at $5.7 million in Q2 2023 and troughed at $2.8 million in Q3 2021.
- A 5-year average of $4.2 million and a median of $4.0 million in 2024 frame the typical range for Research & Development.
- The sharpest annual moves came in 2021 and 2024: Research & Development jumped 145.86% in 2021, then decreased 11.28% in 2024.
- A 5-year view of Research & Development shows it stood at $3.7 million in 2021, then increased by 5.26% to $3.9 million in 2022, then fell by 0.18% to $3.9 million in 2023, then increased by 2.7% to $4.0 million in 2024, then advanced by 21.12% to $4.8 million in 2025.
- Business Quant data shows LUNG's Research & Development at $4.8 million in Q3 2025, $5.3 million in Q2 2025, and $4.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Pulmonx | 54.38 Mn | -15.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.85 Mn |
| Jun 30, 2025 | 5.31 Mn |
| Mar 31, 2025 | 4.76 Mn |
| Dec 31, 2024 | 4.00 Mn |
| Sep 30, 2024 | 3.74 Mn |
| Jun 30, 2024 | 5.62 Mn |
| Mar 31, 2024 | 4.21 Mn |
| Dec 31, 2023 | 3.90 Mn |
| Sep 30, 2023 | 4.22 Mn |
| Jun 30, 2023 | 5.71 Mn |
| Mar 31, 2023 | 4.25 Mn |
| Dec 31, 2022 | 3.90 Mn |
| Sep 30, 2022 | 4.37 Mn |
| Jun 30, 2022 | 3.59 Mn |
| Mar 31, 2022 | 3.53 Mn |
| Dec 31, 2021 | 3.71 Mn |
| Sep 30, 2021 | 2.82 Mn |
| Jun 30, 2021 | 3.51 Mn |
| Mar 31, 2021 | 3.03 Mn |
| Dec 31, 2020 | 2.47 Mn |